ForestRay,  —

Articles by

Phase 1 Trial to Test BDNF Gene Therapy in Alzheimer’s Patients

A Phase 1 trial will evaluate the use of gene therapy in delivering brain-derived neurotrophic factor (BDNF) to the brains of people with Alzheimer’s disease or mild cognitive impairment (MCI), which often precedes dementia. Researchers at the University of California San Diego (UCSD) School of Medicine are preparing to…